Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2017 August;58(4) > The Journal of Cardiovascular Surgery 2017 August;58(4):497-500

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  RECENT DEVELOPMENTS IN THE MANAGEMENT OF IN-STENT RESTENOSIS 

The Journal of Cardiovascular Surgery 2017 August;58(4):497-500

DOI: 10.23736/S0021-9509.17.09955-4

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Drug eluting stents and modern stent technologies for in-stent restenosis

Martin WERNER

Vascular Clinic, Hanusch Hospital, Vienna, Austria


PDF


The implantation of metallic stents has become a standard procedure to improve the outcome after angioplasty of peripheral vessels. However, the occurrence of in-stent restenosis is hampering the long-term efficacy of these procedures and is associated with re-occurrence of symptoms. The optimal treatment modality for in-stent-restenosis in the peripheral vasculature is not well examined. This review discusses the existing evidence for the treatment of in-stent restenosis with drug eluting stents and modern stent technologies.


KEY WORDS: Peripheral artery disease - Coronary restenosis - Coronary stenosis - Drug-eluting stents

top of page